Targeting a key enzyme with gene therapy reversed course of Alzheimer's disease in mouse models
s disease is a progressive neurodegenerative disorder and the most common cause of dementia among the elderly in the United States affecting 4.5-5 million adults - 10 times more than those affected by Parkinson's disease. Starting with mild memory problems and ending with severe brain damage Alzheimer's usually begins after the age of 60 the risk increasing with age.